logo

ALCY

Alchemy Investments·NASDAQ
--
--(--)
--
--(--)
3.76 / 10
Netural

ALCY's fundamental health is rated neutral (3.8/10). Key positives include a strong fixed assets turnover ratio and a favorable current assets to total assets ratio. However, significant headwinds come from low net income to revenue and asset to market value ratios, indicating profitability and valuation concerns. Historical back-tests show modest returns for most factors, reinforcing a defensive stance.

Fundamental(3.76)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.26
Score2/3
Weight18.71%
1M Return2.45%
Current liabilities / Total liabilities (%)
Value39.73
Score2/3
Weight11.37%
1M Return1.79%
Net income-Revenue
Value-0.17
Score1/3
Weight5.75%
1M Return0.82%
Basic earnings per share (YoY growth rate %)
Value-155.36
Score0/3
Weight3.80%
1M Return0.58%
Rate of return on total assets (%)
Value-7.39
Score2/3
Weight11.08%
1M Return1.57%
Fixed assets turnover ratio
Value7979.42
Score3/3
Weight18.58%
1M Return2.65%
Annualized return on total assets (%)
Value-9.85
Score2/3
Weight11.08%
1M Return1.57%
Diluted earnings per share (YoY growth rate %)
Value-155.36
Score0/3
Weight5.91%
1M Return0.91%
Asset-MV
Value-0.50
Score0/3
Weight-1.42%
1M Return-0.23%
Current assets / Total assets (%)
Value4.01
Score3/3
Weight15.16%
1M Return2.31%
Is ALCY fundamentally strong?
  • ALCY scores 3.76/10 on fundamentals and holds a Fair valuation at present. Backed by its -31.22% ROE, 0.00% net margin, -61.93 P/E ratio, 112.93 P/B ratio, and -128.31% earnings growth, these metrics solidify its Netural investment rating.